Not all blood donations are the same, andnot every donor experience is straightforward.

In this episode, we lean on the expertise of Joel Addams,MD, MA, FCAP, Medical Director of Clinical Pathology, to walk through what reallyhappens before, during, and after you donate blood.

From the questions you’ll be asked to why you might be turned away, we unpack the critical differences between screening and testing, what ensures the safety of the blood supply, and where ethics come into play.

But this conversation goes further.

Through the lens of Patient Blood Management, wechallenge the assumption that donating blood is always a simple “yes”—and instead explore how donors and clinicians alike can make informed, thoughtful decisions.

Because this isn’t just about giving blood.
It’s about understanding it.

Have a story or concern about blood donation ethics? Shareit in the comments. We’re listening and may feature it in a future episode.

In this episode, MaryAnn and Dr. Caroline Alquist delve intothe complexities of HLA (Human Leukocyte Antigen) and its critical role in patient blood management. They discuss how HLA serves as a genetic fingerprint that influences transfusion outcomes, the importance of avoiding unnecessarytransfusions, and the ethical considerations surrounding blood donation.

Theconversation also highlights advancements in HLA testing technology and thesignificance of donor diversity in improving blood health, particularly for minority communities. Dr. Alquist emphasizes the need for patient advocacy and understanding of HLA testing to ensure better health outcomes.

Takeaways:

HLA is crucial for understanding immune responses intransfusions.

Transfusion-related immunomodulation (TRIM) can affectpatient outcomes.

Avoiding unnecessary transfusions is a key goal in patientblood management.

HLA typing is essential for patients requiring specializedtransfusions.

Increasing donor diversity is vital for matching patientseffectively.

Virtual cross-matching technology enhances organ allocationefficiency.

HLA typing can predict patient responses to certainmedications.

Blood is a limited resource, and careful management isessential.

Let's Talk PBM Website:https://letstalkpbm.com/

Check out Dr. Alquist's podcast here:

https://youtu.be/QUzsbEG1k-w?si=MLFCYT8zuFVRneKW

In this episode, Syreeta Wright, author, patient advocate, and true warrior, shares what it’s like to live with sickle cell. From the excruciating crises, losing the ability to walk, fighting to avoid donor blood, and the medical trauma incurred as a child. She speaks plainly about feeling violated when her choices were overridden, and how that experience stillaffects her life.

Syreeta explains why sickle cell is not a “Black disease,” how that harmful label helped justify neglect, and why research and resources are still far behind where they should be. She also shows how patient blood management and bloodless medicine became her path; building her own blood, using alternatives, and becoming an exceptionally informed patient who refuses to accept “standard care” without questions.

Syreeta creates a children’s book series to help kids see themselves as warriors, not victims. If you’re a patient, parent, grandparent, clinician, or anyone who has ever felt ignored by the medical system, this conversation will challenge, educate, and inspire you to advocate fiercely for your own body.

🔗 Check out Syreeta’schannel and her “World Warrior” songs here:
https://www.youtube.com/@WelcomeToTheWorldWarrior

Let's Talk PBM Website:

https://letstalkpbm.com/

Music:

Iron and Grace – Music provided by SUNO AI No Copyright.

Bent but Unbroken-Music by Syreeta Wright AI-generated. No Copyright